SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
1-Year Return
71.55%
This Quarter Return
+51.32%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$357M
AUM Growth
+$32.4M
(+10%)
Cap. Flow
-$27M
Cap. Flow
% of AUM
-7.57%
Top 10 Holdings %
Top 10 Hldgs %
41.79%
Holding
95
New
30
Increased
9
Reduced
31
Closed
21
Top Buys
| 1 |
Avidity Biosciences
RNA
|
$12.5M |
| 2 |
C4 Therapeutics
CCCC
|
$11.7M |
| 3 |
Solid Biosciences
SLDB
|
$9.73M |
| 4 |
Perspective Therapeutics
CATX
|
$9.65M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$5.98M |
Top Sells
| 1 |
Mersana Therapeutics
MRSN
|
$15.5M |
| 2 |
MacroGenics
MGNX
|
$11.5M |
| 3 |
Medtronic
MDT
|
$11.1M |
| 4 |
Sanofi
SNY
|
$10.9M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$7.59M |
Sector Composition
| 1 | Healthcare | 99.99% |
